Brookline Capital Acquisition Corp. BCAC
We take great care to ensure that the data presented and summarized in this overview for Brookline Capital Acquisition Corp. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Latest Institutional Activity in BCAC
Top Purchases
Top Sells
About BCAC
Insider Transactions at BCAC
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 23
2023
|
Frank J. Hsu Chief Medical Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
16,354
-100.0%
|
-
|
|
Aug 23
2023
|
Francis Willard Sarena President and COO |
SELL
Sale (or disposition) back to the issuer
|
Direct |
124,296
-100.0%
|
-
|
|
Aug 23
2023
|
Francis Willard Sarena President and COO |
SELL
Payment of exercise price or tax liability
|
Direct |
31,123
-20.03%
|
$0
$0.39 P/Share
|
|
Aug 23
2023
|
Amy Wong SVP, Finance and Operations |
SELL
Sale (or disposition) back to the issuer
|
Direct |
66,565
-100.0%
|
-
|
|
Aug 23
2023
|
Amy Wong SVP, Finance and Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
15,561
-18.95%
|
$0
$0.39 P/Share
|
|
Aug 23
2023
|
Gordon Ringold Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
10,000
-100.0%
|
-
|
|
Aug 23
2023
|
Samuel P Wertheimer Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
146,383
-100.0%
|
-
|
|
Aug 23
2023
|
William E. Duke Chief Financial Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
128,001
-100.0%
|
-
|
|
Aug 23
2023
|
William E. Duke Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
26,416
-17.11%
|
$0
$0.39 P/Share
|
|
Aug 23
2023
|
Xiaodong Yang Chief Executive Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
863,729
-100.0%
|
-
|
|
Aug 23
2023
|
Xiaodong Yang Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
69,161
-7.41%
|
$0
$0.39 P/Share
|
|
Aug 23
2023
|
Xiaodong Yang Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
400,000
+30.01%
|
-
|
|
Jun 15
2023
|
Xiaodong Yang Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
7,001
-1.3%
|
$0
$0.49 P/Share
|
|
Jun 15
2023
|
Amy Wong SVP, Finance and Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
2,777
-3.27%
|
$0
$0.49 P/Share
|
|
Jun 15
2023
|
William E. Duke Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,504
-2.83%
|
$0
$0.49 P/Share
|
|
Jun 15
2023
|
Frank J. Hsu Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,323
-20.91%
|
$0
$0.49 P/Share
|
|
Jun 15
2023
|
Francis Willard Sarena President and COO |
SELL
Payment of exercise price or tax liability
|
Direct |
6,917
-4.26%
|
$0
$0.49 P/Share
|
|
May 23
2023
|
Amy Wong SVP, Finance and Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
12,234
-12.59%
|
$0
$0.4 P/Share
|
|
May 23
2023
|
Amy Wong SVP, Finance and Operations |
BUY
Grant, award, or other acquisition
|
Direct |
75,000
+43.57%
|
-
|
|
May 23
2023
|
William E. Duke Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
17,261
-9.8%
|
$0
$0.4 P/Share
|
Last 12 Months Summary
Buy / Acquisition
0
Shares
From
0
Insiders
Sell / Disposition
0
Shares
From
0
Insiders